The Carlyle Group Inc. 4.625% Subordinated Notes due 2061 (NASDAQ:CGABL) Short Interest Down 67.1% in November

The Carlyle Group Inc. 4.625% Subordinated Notes due 2061 (NASDAQ:CGABL) was the recipient of a significant decline in short interest during the month of November. As of November 30th, there was short interest totalling 13,500 shares, a decline of 67.1% from the November 15th total of 41,000 shares. Based on an average trading volume of 25,800 shares, the short-interest ratio is currently 0.5 days.

Carlyle Group Inc. 4.625% Subordinated Notes due 2061 Stock Performance

Shares of NASDAQ CGABL remained flat at $18.92 during midday trading on Wednesday. 18,446 shares of the company’s stock were exchanged, compared to its average volume of 22,062. Carlyle Group Inc. 4.625% Subordinated Notes due 2061 has a 12-month low of $17.49 and a 12-month high of $20.85. The company’s 50 day moving average price is $19.67 and its 200-day moving average price is $19.12.

Carlyle Group Inc. 4.625% Subordinated Notes due 2061 Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Saturday, November 15th. Shareholders of record on Saturday, November 1st will be given a $0.2891 dividend. The ex-dividend date of this dividend is Friday, October 31st. This represents a $1.16 annualized dividend and a yield of 6.11%.

Carlyle Group Inc. 4.625% Subordinated Notes due 2061 Company Profile

biohaven is engaged in the identification and development of clinical stage compounds targeting the glutamatergic system. biohaven obtained licenses from yale university school of medicine and massachusetts general hospital regarding intellectual property relating to the use of certain glutamate modulating agents in the treatment of neuropsychiatric disorders.